JP2008543961A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2008543961A5 JP2008543961A5 JP2008518703A JP2008518703A JP2008543961A5 JP 2008543961 A5 JP2008543961 A5 JP 2008543961A5 JP 2008518703 A JP2008518703 A JP 2008518703A JP 2008518703 A JP2008518703 A JP 2008518703A JP 2008543961 A5 JP2008543961 A5 JP 2008543961A5
- Authority
- JP
- Japan
- Prior art keywords
- polypeptide
- positions
- residue
- fragment
- native sequence
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE102005029845.1A DE102005029845B4 (de) | 2005-06-27 | 2005-06-27 | Verfahren zur Diagnose von rheumatischen Erkrankungen |
| DE102005029845.1 | 2005-06-27 | ||
| PCT/EP2006/006205 WO2007000320A2 (de) | 2005-06-27 | 2006-06-27 | Verfahren zur diagnose von rheumatischen erkrankungen |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012193246A Division JP2013032358A (ja) | 2005-06-27 | 2012-09-03 | リウマチ疾患の診断方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2008543961A JP2008543961A (ja) | 2008-12-04 |
| JP2008543961A5 true JP2008543961A5 (enExample) | 2009-07-23 |
| JP5174659B2 JP5174659B2 (ja) | 2013-04-03 |
Family
ID=37309237
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008518703A Active JP5174659B2 (ja) | 2005-06-27 | 2006-06-27 | リウマチ疾患の診断方法 |
| JP2012193246A Pending JP2013032358A (ja) | 2005-06-27 | 2012-09-03 | リウマチ疾患の診断方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012193246A Pending JP2013032358A (ja) | 2005-06-27 | 2012-09-03 | リウマチ疾患の診断方法 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US8999921B2 (enExample) |
| EP (1) | EP1896497B1 (enExample) |
| JP (2) | JP5174659B2 (enExample) |
| CN (1) | CN101282989A (enExample) |
| AU (1) | AU2006263942B9 (enExample) |
| CA (1) | CA2614103C (enExample) |
| DE (2) | DE102005029845B4 (enExample) |
| WO (1) | WO2007000320A2 (enExample) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE102005029845B4 (de) | 2005-06-27 | 2017-03-23 | Orgentec Diagnostika Gmbh | Verfahren zur Diagnose von rheumatischen Erkrankungen |
| EP2171449A2 (en) * | 2007-06-20 | 2010-04-07 | Schering Corporation | Joint destruction biomarkers for anti-il-17a therapy of inflammatory joint disease |
| EP2204380A1 (en) | 2008-12-23 | 2010-07-07 | Charité-Universitätsmedizin Berlin | hnRNP A3 related peptides and use thereof for diagnosis of rheumatoid arthritis |
| BRPI1013179A2 (pt) | 2009-03-30 | 2019-09-24 | Prometheus Laboratories Inc | peptídeo sintético, métodos para detectar um anticorpo de proteína anti-citrulinado em uma amostra biológica, para realizar um ensaio para ajudar no diagnóstico ou prognóstico de artrite reumatóide, para melhorar a sensibilidade de diagnosticar ou prognosticar artrite reumatóide, ensaio para diagnosticar ou prognosticar artrite reumatóide, kit, e, método para identificar um peptídeo que é imunologicamente reativo com um anticorpo de proteína anti-citrulinado |
| CN102229652B (zh) * | 2009-10-23 | 2012-05-23 | 山东省医药生物技术研究中心 | 抗类风湿性关节炎的多肽及其在制药中的应用 |
| US10011883B2 (en) | 2011-10-14 | 2018-07-03 | New York University | Causative agents and diagnostic methods relating to rheumatoid arthritis |
| WO2013151314A1 (ko) * | 2012-04-03 | 2013-10-10 | 연세대학교 산학협력단 | 비멘틴을 포함하는 탈모 억제 또는 발모 촉진용 조성물 |
| GB201214007D0 (en) * | 2012-08-07 | 2012-09-19 | Scancell Ltd | Anti-tumour immune responses to modified self-epitopes |
| WO2016199964A1 (ko) * | 2015-06-10 | 2016-12-15 | 주식회사 이뮨메드 | 분리된 비멘틴 유래 펩타이드에 특이적으로 결합하는 항체 또는 상기 펩타이드의 결합 단편 |
| GB201512703D0 (en) | 2015-07-20 | 2015-08-26 | Scancell Ltd | Anti-tumour immune responses to modified self-epitopes |
| CN106950365B (zh) * | 2017-02-15 | 2018-11-27 | 中国医学科学院北京协和医院 | 一种acpa阴性的ra诊断标志物及其应用 |
| GB201815041D0 (en) | 2018-09-14 | 2018-10-31 | Scancell Ltd | Epitopes |
| WO2022108309A1 (ko) * | 2020-11-18 | 2022-05-27 | 한양대학교 에리카산학협력단 | 인산화된 비멘틴의 과도한 생성을 차단하여 암을 예방 또는 치료하는 방법 |
| KR102511660B1 (ko) * | 2020-11-18 | 2023-03-20 | 한양대학교 에리카산학협력단 | 비멘틴 돌연변이체 또는 이를 발현하는 벡터를 유효성분으로 포함하는 암 예방 또는 치료용 약학적 조성물 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE9900473D0 (sv) * | 1999-02-12 | 1999-02-12 | Karolinska Innovations Ab | Inhibitor of endothelial cell proliferation |
| JP2003501381A (ja) * | 1999-06-07 | 2003-01-14 | ユニバーシティ・オブ・シェフィールド | 関節炎の処置 |
| JP2007524583A (ja) * | 2003-03-07 | 2007-08-30 | ロンドン・ヘルス・サイエンシズ・センター・リサーチ・インコーポレーテッド | 自己免疫異常に関わるｈｌａ−ｄｒｍｈｃクラスｉｉ分子に関するペプチド |
| DE102005029845B4 (de) | 2005-06-27 | 2017-03-23 | Orgentec Diagnostika Gmbh | Verfahren zur Diagnose von rheumatischen Erkrankungen |
-
2005
- 2005-06-27 DE DE102005029845.1A patent/DE102005029845B4/de not_active Expired - Fee Related
-
2006
- 2006-06-27 JP JP2008518703A patent/JP5174659B2/ja active Active
- 2006-06-27 DE DE202006020682U patent/DE202006020682U1/de not_active Expired - Lifetime
- 2006-06-27 EP EP06762214.2A patent/EP1896497B1/de active Active
- 2006-06-27 CN CNA2006800312026A patent/CN101282989A/zh active Pending
- 2006-06-27 US US11/597,515 patent/US8999921B2/en active Active
- 2006-06-27 CA CA2614103A patent/CA2614103C/en not_active Expired - Fee Related
- 2006-06-27 AU AU2006263942A patent/AU2006263942B9/en not_active Ceased
- 2006-06-27 WO PCT/EP2006/006205 patent/WO2007000320A2/de not_active Ceased
-
2012
- 2012-09-03 JP JP2012193246A patent/JP2013032358A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Walensky et al. | Hydrocarbon-stapled peptides: principles, practice, and progress: miniperspective | |
| US11013814B2 (en) | Cartilage-homing peptide conjugates and methods of use thereof | |
| AU2012362121B2 (en) | Stabilized antiviral fusion helices | |
| JP2008543961A5 (enExample) | ||
| EP2611825B1 (en) | Solid phase synthesis of h(gly2)glp-2 | |
| JP2020505326A (ja) | Ｔｅａｄ相互作用を妨害するためのペプチド組成物およびその使用方法 | |
| Chen et al. | Inhibiting human calcitonin fibril formation with its most relevant aggregation-resistant analog | |
| Sheard et al. | Peptide multimerization as leads for therapeutic development | |
| Lalani et al. | Review on therapeutic potential of peptides: Advancements in synthesis methods, linear and cyclic peptides, and strategies for overcoming challenges | |
| US10597426B2 (en) | Polypeptide compound and preparation method and use thereof | |
| US20180244724A1 (en) | Polypeptide compound and preparation method and use thereof | |
| Enyedi et al. | Development of cyclic NGR peptides with thioether linkage: structure and dynamics determining deamidation and bioactivity | |
| WO2017101786A1 (zh) | 一种多肽化合物及其制备方法与应用 | |
| CA3093588A1 (en) | Truncated cartilage-homing peptides and peptide complexes and methods of use thereof | |
| US10738083B2 (en) | Influenza virus neutralizing peptidomimetic compounds | |
| CN110234337A (zh) | 中和流感病毒的化合物 | |
| Little et al. | Evolution of branched peptides as novel biomaterials | |
| US20130225508A1 (en) | Peptide capable of binding to immunoglobulin | |
| Trinidad-Calderón | School of Engineering and Sciences | |
| MPharm | Peptide-mimetic hydrogels as a long-acting drug delivery platform for HIV/AIDS | |
| Wahyudi et al. | Targeting Disease-Related Proteins via Secondary Protein Structure Formation | |
| Parlak | Peptide-based drug systems | |
| Smyrniotou et al. | 2-Oxoamides based on dipeptides and pseudodipeptides as inhibitors of Ca2+-independent phospholipase A2 | |
| EP1932852A1 (en) | Novel taxane related peptides and uses thereof |